Through participation in the Nucleate UK Activator Programme, we were awarded $200,000 from Blueyard and invited to speak at the Nucleate Forum (UK) and Nucleate Summit (San Francisco).

Following participation in the UKRI backed Science Creates Accelerator we successfully secured funding for a feasibility study.

Xterna CEO was awarded at an evening celebrating translational contributions of Francis Crick Institute scientists.

Its time for the team to expand! Seeking experts in nucleic acids and immunology. If you’re obsessed with the power of XNA, welcome!

Xterna joins the Bioinnovation Institute Venture Lab programme for 2025/2026. Following a therapeutics focused strand. Watch this space for further updates.

The team expands, a warm welcome to Rob who brings expertise across immuno-oncology and RNA therapeutics.

Back to our roots, as previous Cambridge alum, the team joined the inaugural Founders at the University of Cambridge programme, sponsored by AstraZeneca.